Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
2024年10月24日 - 8:08PM
ビジネスワイヤ（英語）
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company
committed to advancing new standards of care for the frontline
treatment of hematologic malignancies, today announced that it will
host a live conference call and webcast at 8:30 a.m. ET on
Thursday, October 31, 2024 to report its third quarter 2024
financial results and provide a business update.
To access the live conference call, please dial (800) 549-8228
(domestic) or (289) 819-1520 (international) and refer to
conference ID 07454. A webcast of the call will also be available
on the Investors & Media section of the Syros website at
www.syros.com. An archived replay of the webcast will be available
for approximately 30 days following the call.
About Syros Pharmaceuticals Syros is committed to
developing new standards of care for the frontline treatment of
patients with hematologic malignancies. Driven by the motivation to
help patients with blood disorders that have largely eluded other
targeted approaches, Syros is developing tamibarotene, an oral
selective RARα agonist in frontline patients with higher-risk
myelodysplastic syndrome with RARA gene overexpression. For more
information, visit www.syros.com and follow us on Twitter
(@SyrosPharma) and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241024190576/en/
Syros Karen Hunady Director of Corporate Communications
& Investor Relations 1-857-327-7321 khunady@syros.com
Investors Amanda Isacoff Precision AQ 212-362-1200
amanda.isacoff@precisionaq.com
Syros Pharmaceuticals (NASDAQ:SYRS)
過去 株価チャート
から 10 2024 まで 11 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
過去 株価チャート
から 11 2023 まで 11 2024
